Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 39.35
-1.15 (-2.84%)
Mar 9, 2026, 1:21 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 5.08 billion as of March 9, 2026. Its market cap has decreased by -35.39% in one year.
Market Cap
5.08B
Enterprise Value
3.97B
Revenue
136.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.35
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 5.08B, an increase of 4.56%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.23B | -21.97% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 5.23B |
| Panion & Bf Biotech | 5.25B |
| Locus Cell | 5.30B |
| AnnJi Pharmaceutical | 5.30B |
| CHO Pharma | 5.34B |
| UnicoCell Biomed | 5.09B |
| Steminent Biotherapeutics | 5.42B |
| Sinphar Pharmaceutical | 5.86B |